by Cara MurezPatients with sickle cell disease may soon have two new treatments to try.On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a newgene thera
by Cara MurezPatients with sickle cell disease may soon have two new treatments to try.On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a newgene thera
(HealthDay)—From 2009 to 2016, the incidence of thyroid cancer reached a plateau and possibly started to decline, according to a research letter published in the Dec. 24/31 issue of theJournal o
(HealthDay)—From 2009 to 2016, the incidence of thyroid cancer reached a plateau and possibly started to decline, according to a research letter published in the Dec. 24/31 issue of theJournal o
July 10, 2021Kristi RosaPatients with a urological cancer who were also infected with COVID-19 and undergoing elective surgery for their disease, were found to have a significantly higher likelihood o
July 10, 2021Kristi RosaPatients with a urological cancer who were also infected with COVID-19 and undergoing elective surgery for their disease, were found to have a significantly higher likelihood o
byThe Mount Sinai HospitalMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Researchers at the Icahn School of Medicine at
byThe Mount Sinai HospitalMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Researchers at the Icahn School of Medicine at
byUniversity College LondonCredit: Unsplash/CC0 Public DomainThe INTERLACE phase III trial assessed whether a short course of induction chemotherapy (IC) prior to chemoradiation (CRT) could redu
byUniversity College LondonCredit: Unsplash/CC0 Public DomainThe INTERLACE phase III trial assessed whether a short course of induction chemotherapy (IC) prior to chemoradiation (CRT) could redu
by Nina Grötschl,University of Veterinary Medicine—ViennaCredit: Pixabay/CC0 Public DomainThe oncogene EVI1 causes an aggressive type of leukemia, but its exact function has been a mystery. A re
by Nina Grötschl,University of Veterinary Medicine—ViennaCredit: Pixabay/CC0 Public DomainThe oncogene EVI1 causes an aggressive type of leukemia, but its exact function has been a mystery. A re
byEmory UniversityHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0A targeted therapy for children with high-risk Hodgkin l
byEmory UniversityHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0A targeted therapy for children with high-risk Hodgkin l
byJohns Hopkins University School of MedicineAn impressionist painting of a liquid biopsy. Credit: Valsamo Anagnostou x DALL-E, openAILiquid biopsies are blood tests that can serially measure ci
byJohns Hopkins University School of MedicineAn impressionist painting of a liquid biopsy. Credit: Valsamo Anagnostou x DALL-E, openAILiquid biopsies are blood tests that can serially measure ci
New data released demonstrates that the addition of Zometa (zoledronic acid) injection to standard chemotherapy before breast cancer surgery reduces the size of breast tumors more effectively than che
New data released demonstrates that the addition of Zometa (zoledronic acid) injection to standard chemotherapy before breast cancer surgery reduces the size of breast tumors more effectively than che
by Frontiers JournalsCredit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0935-0Cong Peng and others at the Department of Dermatology, Xiangya Hospital, Central South University, Ch
by Frontiers JournalsCredit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0935-0Cong Peng and others at the Department of Dermatology, Xiangya Hospital, Central South University, Ch